MSH6 and neoplasm: Both the mean age (38 years) and the age of patients harboring MSH6 and PMS2 germline P/LP variants in the CNS LS-related tumor group were significantly lower than those in the other two groups, while there was no significant difference in the age distribution among the 4 MMR genes in the CNS LS-related tumor group.